SCHEMBL10018862

SCHEMBL10018862

CC1(C)c2ccccc2-c2cc(-c3cccc4c3sc3c(-c5ccc6c(c5)-c5ccccc5C6(C)C)cccc34)ccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.44
TDO2 P48775 3/20 0.35
LIMK1 P53667 1/20 0.34
PGR P06401 4/20 0.33
PDK2 Q15119 6/20 0.32
PRKDC P78527 1/20 0.32
MLNR O43193 1/20 0.31
NR1I2 O75469 1/20 0.31
CHRM2 P08172 1/20 0.31
ADRB1 P08588 1/20 0.31
HTR1A P08908 1/20 0.31
ADRA2A P08913 1/20 0.31
CHRM1 P11229 1/20 0.31
DRD2 P14416 1/20 0.31
ADRA2B P18089 1/20 0.31
ADRA2C P18825 1/20 0.31
CHRM3 P20309 1/20 0.31
DRD1 P21728 1/20 0.31
SLC6A2 P23975 1/20 0.31
HTR2A P28223 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17057190 0.93 ALOX5 (0.40) ALOX5TDO2LIMK1PGRPDK2
SCHEMBL10018859 0.91 ALOX5 (0.44) ALOX5TDO2LIMK1PGRPDK2
SCHEMBL10018876 0.89 ALOX5 (0.39) ALOX5TDO2LIMK1PGRPDK2
SCHEMBL17640303 0.89 LIMK1 (0.38) ALOX5TDO2LIMK1RARBRARG
SCHEMBL17640348 0.88 ALOX5 (0.36) ALOX5TDO2LIMK1
SCHEMBL17425727 0.86 LIMK1 (0.36) ALOX5TDO2LIMK1RARBRARG
SCHEMBL17057191 0.85 PDK2 (0.42) ALOX5LIMK1PGRPDK2
SCHEMBL10018872 0.84 PDK2 (0.35) ALOX5PGRPDK2RARBRARG
SCHEMBL17425595 0.84 LIMK1 (0.37) ALOX5TDO2LIMK1
SCHEMBL17200998 0.84 ALOX5 (0.39) ALOX5LIMK1PDK2PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8743031-B2 Dibenzothiophene compound and organic light-emitting element based on the same CANON KABUSHIKI KAISHA (JP) 2014-06-03 US disclosed
US-8743031-B2 Dibenzothiophene compound and organic light-emitting element based on the same CANON KABUSHIKI KAISHA (JP) 2014-06-03 US disclosed
US-20120075171-A1 DIBENZOTHIOPHENE COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT BASED ON THE SAME CANON KABUSHIKI KAISHA (JP) 2012-03-29 US disclosed
US-20120075171-A1 DIBENZOTHIOPHENE COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT BASED ON THE SAME CANON KABUSHIKI KAISHA (JP) 2012-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120075171-A1 DIBENZOTHIOPHENE COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT BASED ON THE SAME TPT1, RFT1, ARNT ALOX5 2608/4885TDO2 13/4885LIMK1 2383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.